Annual non current assets:
$686.33M-$72.50M(-9.55%)Summary
- As of today (July 7, 2025), RARE annual long term assets is $686.33 million, with the most recent change of -$72.50 million (-9.55%) on December 31, 2024.
- During the last 3 years, RARE annual non current assets has risen by +$20.54 million (+3.09%).
- RARE annual non current assets is now -9.55% below its all-time high of $758.83 million, reached on December 31, 2023.
Performance
RARE Non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly non current assets:
$612.77M-$73.56M(-10.72%)Summary
- As of today (July 7, 2025), RARE quarterly long term assets is $612.77 million, with the most recent change of -$73.56 million (-10.72%) on March 31, 2025.
- Over the past year, RARE quarterly non current assets has dropped by -$98.34 million (-13.83%).
- RARE quarterly non current assets is now -19.25% below its all-time high of $758.83 million, reached on December 31, 2023.
Performance
RARE quarterly non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Non current assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RARE Non current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | -13.8% |
| 3 y3 years | +3.1% | -9.4% |
| 5 y5 years | +141.3% | +80.8% |
RARE Non current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.6% | +3.8% | -19.3% | +1.1% |
| 5 y | 5-year | -9.6% | +141.3% | -19.3% | +54.6% |
| alltime | all time | -9.6% | >+9999.0% | -19.3% | >+9999.0% |
RARE Non current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $612.77M(-10.7%) |
| Dec 2024 | $745.03M(+1.8%) | $686.33M(-7.1%) |
| Sep 2024 | - | $738.75M(+13.0%) |
| Jun 2024 | - | $653.80M(-8.1%) |
| Mar 2024 | - | $711.11M(-6.3%) |
| Dec 2023 | $732.18M(-17.2%) | $758.83M(+18.8%) |
| Sep 2023 | - | $638.95M(+4.9%) |
| Jun 2023 | - | $609.17M(-1.3%) |
| Mar 2023 | - | $617.07M(-6.7%) |
| Dec 2022 | $883.90M(+3.2%) | $661.54M(+9.2%) |
| Sep 2022 | - | $605.81M(-5.7%) |
| Jun 2022 | - | $642.09M(-5.1%) |
| Mar 2022 | - | $676.51M(+1.6%) |
| Dec 2021 | $856.60M(-33.9%) | $665.79M(+4.4%) |
| Sep 2021 | - | $637.92M(+13.3%) |
| Jun 2021 | - | $562.95M(+6.9%) |
| Mar 2021 | - | $526.83M(+13.5%) |
| Dec 2020 | $1.30B(+52.2%) | $464.25M(+17.1%) |
| Sep 2020 | - | $396.38M(-2.8%) |
| Jun 2020 | - | $408.00M(+20.4%) |
| Mar 2020 | - | $338.82M(+19.1%) |
| Dec 2019 | $851.02M | $284.48M(+6.8%) |
| Sep 2019 | - | $266.46M(+2.7%) |
| Jun 2019 | - | $259.50M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $220.87M(+12.0%) |
| Dec 2018 | $522.37M(+93.8%) | $197.19M(-0.2%) |
| Sep 2018 | - | $197.66M(-1.8%) |
| Jun 2018 | - | $201.28M(-14.6%) |
| Mar 2018 | - | $235.77M(+6.6%) |
| Dec 2017 | $269.58M(-32.9%) | $221.17M(+401.0%) |
| Sep 2017 | - | $44.14M(-43.2%) |
| Jun 2017 | - | $77.75M(-23.1%) |
| Mar 2017 | - | $101.14M(-27.2%) |
| Dec 2016 | $401.69M(-10.8%) | $138.93M(+41.2%) |
| Sep 2016 | - | $98.38M(+38.8%) |
| Jun 2016 | - | $70.87M(-24.6%) |
| Mar 2016 | - | $93.95M(-14.1%) |
| Dec 2015 | $450.21M(+132.8%) | $109.36M(-22.7%) |
| Sep 2015 | - | $141.42M(+2084.5%) |
| Jun 2015 | - | $6.47M(+21.6%) |
| Mar 2015 | - | $5.33M(+17.0%) |
| Dec 2014 | $193.42M(+250.2%) | $4.55M(+8.6%) |
| Sep 2014 | - | $4.19M(-4.1%) |
| Jun 2014 | - | $4.37M(+42.3%) |
| Mar 2014 | - | $3.07M(-30.6%) |
| Dec 2013 | $55.23M(-36.1%) | $4.42M(+130.8%) |
| Sep 2013 | - | $1.92M(+2.5%) |
| Dec 2012 | $86.44M(+689.2%) | $1.87M |
| Dec 2011 | $10.95M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual long term assets?
- What is the all time high annual non current assets for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual non current assets year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly long term assets?
- What is the all time high quarterly non current assets for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly non current assets year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual long term assets?
The current annual non current assets of RARE is $686.33M
What is the all time high annual non current assets for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual long term assets is $758.83M
What is Ultragenyx Pharmaceutical Inc. annual non current assets year-on-year change?
Over the past year, RARE annual long term assets has changed by -$72.50M (-9.55%)
What is Ultragenyx Pharmaceutical Inc. quarterly long term assets?
The current quarterly non current assets of RARE is $612.77M
What is the all time high quarterly non current assets for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly long term assets is $758.83M
What is Ultragenyx Pharmaceutical Inc. quarterly non current assets year-on-year change?
Over the past year, RARE quarterly long term assets has changed by -$98.34M (-13.83%)